 - Patients must have adequate pulmonary function studies 50 of predicted on mechanical aspects and diffusion capacity DLCO 50 of predicted within 90 days prior to registration. If the patient is unable to complete pulmonary function tests due to MM-related pain or condition, exception may be granted if the principal investigator documents that the patient is a candidate for high-dose therapy. 